{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:30:33Z","timestamp":1772803833776,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.taap.2021.115698","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T01:45:35Z","timestamp":1629510335000},"page":"115698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model"],"prefix":"10.1016","volume":"429","author":[{"given":"Zhihong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengmin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.taap.2021.115698_bb0005","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bcp.2015.04.013","article-title":"The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain","volume":"97","author":"Bagdas","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2021.115698_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.11.047","article-title":"Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model","volume":"612","author":"Bartlett","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2021.115698_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916688016","article-title":"Dendritic spine dysgenesis in superficial dorsal horn sensory neurons after spinal cord injury","volume":"13","author":"Cao","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.taap.2021.115698_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuroscience.2017.02.055","article-title":"Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats","volume":"349","author":"Carey","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.taap.2021.115698_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.11607\/ofph.1961","article-title":"Antinociception induced by copper salt revisited: interaction with ketamine in formalin-induced intraplantar and orofacial pain in mice","volume":"32","author":"Cazanga","year":"2018","journal-title":"J. Oral Facial Pain Headache"},{"key":"10.1016\/j.taap.2021.115698_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2017.07.023","article-title":"Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury","volume":"125","author":"Chen","year":"2017","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.taap.2021.115698_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015756","article-title":"Opioid analgesics are the leading cause of adverse drug reactions in the obstetric population in South Korea","volume":"98","author":"Choi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.taap.2021.115698_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2019.04.028","article-title":"Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model","volume":"153","author":"Colciaghi","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115698_bb0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fncel.2014.00252","article-title":"Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling","volume":"8","author":"Courtney","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.taap.2021.115698_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2016.00047","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin promotes neuronal regeneration after spinal cord injury","volume":"7","author":"Crupi","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2021.115698_bb0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115698_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.phrs.2016.10.007","article-title":"Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems","volume":"114","author":"Deng","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2021.115698_bb0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35242.044","article-title":"Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice","author":"Fan","year":"2018","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.taap.2021.115698_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2009.00300.x","article-title":"Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents","volume":"158","author":"Florio","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115698_bb0075","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/JPR.S160779","article-title":"Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain","volume":"11","author":"Gao","year":"2018","journal-title":"J. Pain Res."},{"issue":"3","key":"10.1016\/j.taap.2021.115698_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm.3090","article-title":"Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression","volume":"19","author":"Golden","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.taap.2021.115698_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-014-1255-6","article-title":"Intracisternal injection of palmitoylethanolamide inhibits the peripheral nociceptive evoked responses of dorsal horn wide dynamic range neurons","volume":"122","author":"Gonzalez-Hernandez","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/j.taap.2021.115698_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pain.2010.03.005","article-title":"Upregulations of P2X (3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats","volume":"149","author":"Hori","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.taap.2021.115698_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2014.04.030","article-title":"Fucoidan attenuates the existing allodynia and hyperalgesia in a rat model of neuropathic pain","volume":"571","author":"Hu","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.taap.2021.115698_bb0100","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2174\/1389450120666190308144448","article-title":"Significance and mechanisms of P-glycoprotein in central nervous system diseases","volume":"20","author":"Huang","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.taap.2021.115698_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cne.20980","article-title":"Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats","volume":"497","author":"Kim","year":"2006","journal-title":"J. Comp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2021.115698_bb0110","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/j.pain.0000000000000118","article-title":"Spinal excitatory mechanisms of pathological pain","volume":"156","author":"Kuner","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.taap.2021.115698_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2015.05.038","article-title":"Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics","volume":"97","author":"Lee","year":"2015","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.taap.2021.115698_bb0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/j.pain.0000000000001152","article-title":"Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice","volume":"159","author":"Lee","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.taap.2021.115698_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0304-3959(00)00250-5","article-title":"Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers","volume":"85","author":"Li","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.taap.2021.115698_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fphar.2019.00053","article-title":"LPM580098, a novel triple reuptake inhibitor of serotonin, noradrenaline, and dopamine, attenuates neuropathic pain","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.taap.2021.115698_bb0135","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s11064-019-02843-z","article-title":"N-methyl-D-aspartate receptors in the prelimbic cortex are critical for the maintenance of neuropathic pain","volume":"44","author":"Medeiros","year":"2019","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.taap.2021.115698_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2015.05.043","article-title":"Biochemical computation for spine structural plasticity","volume":"87","author":"Nishiyama","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2021.115698_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2018.03.030","article-title":"Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain","volume":"674","author":"Sharma","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"305","key":"10.1016\/j.taap.2021.115698_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2016.02.021","article-title":"Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors","volume":"15","author":"Smith","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.taap.2021.115698_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2019.1570845","article-title":"A meta-analysis of naldemedine for the treatment of opioid-induced constipation","volume":"12","author":"Song","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2021.115698_bb0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2014.11.024","article-title":"Dendritic spine dysgenesis in neuropathic pain","volume":"601","author":"Tan","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.taap.2021.115698_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.expneurol.2011.08.028","article-title":"Rac1-regulated dendritic spine remodeling contributes to neuropathic pain after peripheral nerve injury","volume":"232","author":"Tan","year":"2011","journal-title":"Exp. Neurol."},{"issue":"15\u201316","key":"10.1016\/j.taap.2021.115698_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.drudis.2012.02.010","article-title":"Translation of drug effects from experimental models of neuropathic pain and analgesia to humans","volume":"17","author":"Taneja","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.taap.2021.115698_bb0175","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ALN.0000000000000993","article-title":"Activation of peripheral \u03bc-opioid receptors by dermorphin [D-Arg2, Lys4] (1-4) amide leads to modality-preferred inhibition of neuropathic pain","volume":"124","author":"Tiwari","year":"2016","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.taap.2021.115698_bb0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/j.pain.0000000000001768","article-title":"Activation of \u03bc-\u03b4 opioid receptor heteromers inhibits neuropathic pain behavior in rodents","volume":"161","author":"Tiwari","year":"2020","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.taap.2021.115698_bb0185","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/acschemneuro.1c00043","article-title":"Tozasertib attenuates neuropathic pain by interfering with aurora kinase and KIF11 mediated nociception","volume":"12","author":"Uniyal","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115698_bb0190","doi-asserted-by":"crossref","first-page":"135751","DOI":"10.1016\/j.neulet.2021.135751","article-title":"Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry","volume":"754","author":"Vaidya","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.taap.2021.115698_bb0195","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1074\/jbc.M114.614420","article-title":"Phosphorylation of synaptic GTPase-activating protein (synGAP) by Ca2+\/calmodulin-dependent protein kinase II (CaMKII) and cyclin-dependent kinase 5 (CDK5) alters the ratio of its GAP activity toward Ras and rap GTPases","volume":"290","author":"Walkup","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115698_bb0200","doi-asserted-by":"crossref","first-page":"113926","DOI":"10.1016\/j.bcp.2020.113926","article-title":"PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala","volume":"177","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.taap.2021.115698_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj20030380","article-title":"Post-synaptic density-95 promotes calcium\/calmodulin-dependent protein kinase II-mediated Ser847 phosphorylation of neuronal nitric oxide synthase","volume":"372","author":"Watanabe","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2021.115698_bb0210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.4103\/1673-5374.235074","article-title":"Puerarin ameliorates allodynia and hyperalgesia in rats with peripheral nerve injury","volume":"13","author":"Xie","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.taap.2021.115698_bb0215","doi-asserted-by":"crossref","first-page":"104288","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.07.004","article-title":"Clematichinenoside facilitates recovery of neurological and motor function in rats after cerebral ischemic injury through inhibiting Notch\/NF-\u03baB pathway","volume":"28","author":"Xu","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.taap.2021.115698_bb0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.taap.2018.01.015","article-title":"H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo","volume":"341","author":"Yang","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2021.115698_bb0225","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1007\/s12035-017-0780-3","article-title":"Inhibition of beta-ARK1 ameliorates morphine-induced tolerance and hyperalgesia via modulating the activity of spinal NMDA receptors","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.taap.2021.115698_bb0230","first-page":"12748","article-title":"Phosphorylated neuronal nitric oxide synthase in neuropathic pain in rats","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.taap.2021.115698_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2018.03.004","article-title":"Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1\/CXCR2 signaling pathway","volume":"135","author":"Zhou","year":"2018","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.taap.2021.115698_bb0240","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00213-018-4915-7","article-title":"Novel antidepressant effects of Paeonol alleviate neuronal injury with concomitant alterations in BDNF, Rac1 and RhoA levels in chronic unpredictable mild stress rats","volume":"235","author":"Zhu","year":"2018","journal-title":"Psychopharmacology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:55:22Z","timestamp":1758574522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":48,"alternative-id":["S0041008X21003021"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115698","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115698"}}